Science Current Events | Science News | Brightsurf.com
 

Anti-HIV drug simulation offers 'realistic' tool to predict drug resistance and viral mutation

September 04, 2012
Computer model should help develop better anti-HIV drug combination therapies

Pooling data from thousands of tests of the antiviral activity of more than 20 commonly used anti-HIV drugs, AIDS experts at Johns Hopkins and Harvard universities have developed what they say is the first accurate computer simulation to explain drug effects. Already, the model clarifies how and why some treatment regimens fail in some patients who lack evidence of drug resistance. Researchers say their model is based on specific drugs, precise doses prescribed, and on "real-world variation" in how well patients follow prescribing instructions.

Johns Hopkins co-senior study investigator and infectious disease specialist Robert Siliciano, M.D., Ph.D., says the mathematical model can also be used to predict how well a patient is likely to do on a specific regimen, based on their prescription adherence. In addition, the model factors in each drug's ability to suppress viral replication and the likelihood that such suppression will spur development of drug-resistant, mutant HIV strains.

"With the help of our simulation, we can now tell with a fair degree of certainty what level of viral suppression is being achieved - how hard it is for the virus to grow and replicate - for a particular drug combination, at a specific dosage and drug concentration in the blood, even when a dose is missed," says Siliciano, a professor at the Johns Hopkins University School of Medicine and a Howard Hughes Medical Institute investigator. This information, he predicts, will remove "a lot of the current trial and error, or guesswork, involved in testing new drug combination therapies."

Siliciano says the study findings, to be reported in the journal Nature Medicine online Sept. 2, should help scientists streamline development and clinical trials of future combination therapies, by ruling out combinations unlikely to work.

One application of the model could be further development of drug combinations that can be contained in a single pill taken once a day. That could lower the chance of resistance, even if adherence is not perfect. Such future drug regimens, he says, will ideally strike a balance between optimizing viral suppression and minimizing risk of drug resistance.

Researchers next plan to expand their modeling beyond blood levels of virus to other parts of the body, such as the brain, where antiretroviral drug concentrations can be different from those measured in the blood. They also plan to expand their analysis to include multiple-drug-resistant strains of HIV.

Besides Siliciano, Johns Hopkins joint medical-doctoral student Alireza Rabi was a co-investigator in this study. Other study investigators included doctoral candidates Daniel Rosenbloom, M.S.; Alison Hill, M.S.; and co-senior study investigator Martin Nowak, Ph.D. - all at Harvard University.

Funding support for this study, which took two years to complete, was provided by the National Institutes of Health, with corresponding grant numbers R01-MH54907, R01-AI081600, R01-GM078986; the Bill and Melinda Gates Foundation; the Cancer Research Institute; the National Science Foundation; the Howard Hughes Medical Institute; Natural Sciences and Engineering Research Council of Canada; the John Templeton Foundation; and J. Epstein.

Currently, an estimated 8 million of the more than 34 million people in the world living with HIV are taking antiretroviral therapy to keep their disease in check. An estimated 1,178,000 in the United States are infected, including 23,000 in the state of Maryland.

###

For additional information, go to:

http://www.hopkinsmedicine.org/pharmacology_molecular_sciences/faculty/bios/siliciano.html

http://www.hhmi.org/research/investigators/siliciano_bio.html

http://www.nature.com/nm/index.html

Johns Hopkins Medicine


Related Combination Therapies Current Events and Combination Therapies News Articles


Targeted therapy shows effectiveness against a subtype of the brain tumor medulloblastoma
A targeted therapy already used to treat advanced skin cancer is also effective against the most common subtype of the brain tumor medulloblastoma in adults and should be considered for treatment of newly diagnosed patients, according to research led by St. Jude Children's Research Hospital.

Patient cancer cells help to test treatments
A study, published today in Cell, demonstrates the power of organoids to capture, in three dimensions, the multiple mutations that occur in tumours.

TGen-UCSF study in Neuro-Oncology provides comprehensive look at brain cancer treatments
Led by the Translational Genomics Research Institute (TGen) and UC San Francisco (UCSF), a comprehensive genetic review of treatment strategies for glioblastoma brain tumors was published today in the Oxford University Press journal Neuro-Oncology.

Researchers make key malarial drug-resistence finding
According to the World Health Organization's 2014 World Malaria Report, there are an estimated 198 million cases of malaria worldwide with 3.3 billion people at risk for contracting the infection.

Red Journal's May issue focuses on the vital role of RT in modern lymphoma treatment
The "Radiation and the Modern Management of Lymphoma" issue (May 1, 2015) of the International Journal of Radiation Oncology * Biology * Physics (Red Journal), the official scientific journal of the American Society for Radiation Oncology (ASTRO), is focused on the integral role of radiation therapy in current lymphoma treatment.

Restoring cellular energy signals may treat mitochondrial diseases in humans
Rooted in malfunctions in the tiny power plants that energize our cells, mitochondrial disorders are notoriously complex and variable, with few effective treatments. Now, novel findings in microscopic worms may hold great promise for children and adults with mitochondrial disorders.

A call to action for 2 cancer research fronts to join forces
Since President Nixon declared the "War on Cancer" in 1971, scientists have been united in a quest to find all gene deletions, insertions, or duplications that can cause an otherwise ordinary cell to divide uncontrollably.

Researchers find new approach to treat drug-resistant HER2-positive breast cancer
Resistance to therapy is a major problem in the cancer field. Even when a treatment initially works, the tumors often find ways around the therapy. Using human cell lines of the HER2-positive breast cancer subtype, researchers from the UNC School of Medicine and UNC Lineberger Comprehensive Cancer Center have detailed the surprising ways in which resistance manifests and how to defeat it before it happens.

Review highlights potential of cancer immunotherapy plus targeted therapy
The prospect of combining genomically targeted therapies with drugs that free the immune system to attack cancer suggests "we are finally poised to deliver curative therapies to cancer patients," researchers at The University of Texas MD Anderson Cancer Center note in a review in the April 9 edition of Cell.

Central signaling pathway in lymphoma can be blocked successfully
Cancer researchers from the University of Zurich have identified a key signaling pathway in B-cell lymphoma, a malignant type of blood cancer.
More Combination Therapies Current Events and Combination Therapies News Articles

basic clinical massage therapy: a combination of anatomy and Therapy (Hardcover)

basic clinical massage therapy: a combination of anatomy and Therapy (Hardcover)
by ZHAN MU SI ?H ?KE LAI (Author)


brand new

Combination Cancer Therapy: Modulators and Potentiators (Cancer Drug Discovery and Development)

Combination Cancer Therapy: Modulators and Potentiators (Cancer Drug Discovery and Development)
by Gary K. Schwartz (Editor)


Expert physician-scientists and clinicians review those combinations of novel target agents classic chemotherapies that hold the most promise for the future of medical oncology, and detail their optimal sequence, pharmacokinetic interactions, and interaction with downstream cellular signals. The combinations run the gamut of targeted therapies against cell surface receptors (EGF-R and HER2), the cell cycle (the CDKs), signal transduction events (PKC and NF-kB), apoptosis (bcl-2), as well as focused therapies in ovarian cancer, hematologic diseases, and breast cancer. The authors emphasize novel translational approaches that are rapidly moving from the laboratory bench top to the patient's bedside for the future treatments in cancer therapy.

Textbook of Facial Rejuvenation: The Art of Minimally Invasive Combination Therapy

Textbook of Facial Rejuvenation: The Art of Minimally Invasive Combination Therapy
by Nicholas J. Lowe (Editor), Alastair Carruthers (Editor), Jean Carruthers (Editor), Zoe Diana Draelos (Editor), Richard Glogau (Editor), Christopher Griffiths (Editor), Arnold W. Klein (Editor), Gary Lask (Editor)


In recent years the demand for rejuvenating treatments for the face has grown dramatically for both men and women. Alongside that demand, a wide variety of treatments have evolved, and a combination of different treatments can often result in much greater improvement than single-treatment approaches. With contributions from an impressive cast of international experts, Textbook of Facial Rejuvenation details current treatments, recommends approaches, and suggests how they may be tailored towards individual needs and combined for optimum results.

Antiepileptic Drugs: Combination Therapy and Interactions

Antiepileptic Drugs: Combination Therapy and Interactions
by Jerzy Majkowski (Editor), Blaise F. D. Bourgeois (Editor), Philip N. Patsalos (Editor), Richard H. Mattson (Editor)


This book reviews the use of antiepileptic drugs focusing on the interactions between these drugs and between antiepileptics and other drugs. These interactions can be beneficial or can cause harm. The aim of this book is to increase awareness of the possible impact of combination pharmacotherapies. Pharmacokinetic and pharmacodynamic interactions are discussed supported by clinical and experimental data. The book consists of five sections covering the general concepts and advantages of combination therapies, the principles of drug interactions, the mechanisms of interactions, drug interactions in specific populations or in patients with co-morbid health conditions, and concludes with a look at the future directions for this field of research. The book will be of interest to all who...

Therapy and the Postpartum Woman: Notes on Healing Postpartum Depression for Clinicians and the Women Who Seek their Help

Therapy and the Postpartum Woman: Notes on Healing Postpartum Depression for Clinicians and the Women Who Seek their Help
by Karen Kleiman (Author)


This book provides a comprehensive look at effective therapy for postpartum depression. Using a blend of professional objectivity, evidence-based research, and personal, straight-forward suggestions gathered from years of experience, this book brings the reader into the private world of therapy with the postpartum woman. Based on Psychodynamic and Cognitive-Behavioral theories, and on D.W. Winnicott's "good-enough mother" and the "holding environment" in particular, the book is written by a therapist who has specialized in the treatment of postpartum depression for over 20 years. Therapy and the Postpartum Woman will serve as a companion tool for clinicians and the women they treat.

Hematology - Oncology Therapy

Hematology - Oncology Therapy
by Michael Boyiadzis (Author), James Frame (Author), David R. Kohler (Author), Tito Fojo (Author)


The Essential Therapy Guide to Cancer, Hematologic Disorders, and Supportive Care--Updated with the Latest Treatment Regimens More than 500 treatment regimens Hematology-Oncology Therapy, Second Edition is an up-to-date, comprehensive therapy guide that delivers more than 500 treatment regimens in a succinct, uniform manner. The unique tabular design allows you to instantly locate and implement the proper treatment regimen. Supported by the latest practice guidelines, peer-reviewed literature, and the opinion of experts, Hematology-Oncology Therapy integrates extensive information that is critical to both office- and hospital-based practice of hematology and oncology. Hematology-Oncology Therapy is divided into three sections: Oncology:
Provides detailed information about the...

Doing Couple Therapy: Craft and Creativity in Work with Intimate Partners (Guilford Family Therapy)

Doing Couple Therapy: Craft and Creativity in Work with Intimate Partners (Guilford Family Therapy)
by Robert Taibbi (Author)


Wise, compassionate, and highly practical, this engaging text covers the entire process of therapeutic work with couples, from opening sessions and assessment through skills building, core issues, and termination. Students and novice couple therapists learn effective strategies for intervening with couples of any age who are struggling with acute crises or longstanding conflicts and power struggles. Rich with sensitive, detailed case material, the book features numerous exercises that help readers identify and develop their own strengths as practitioners. Self-care strategies and tips for getting the most out of supervision are provided. Special topics include how to address couple issues with only one partner and couple therapy applications for chronic mental health problems....

Orthopaedic Physical Therapy Secrets, 2e

Orthopaedic Physical Therapy Secrets, 2e
by Jeffrey D. Placzek MD PT (Author), David A. Boyce PT EOD OCS ECS (Author)


Part of the popular Secrets series, this helpful reference presents basic physical therapy concepts and then introduces different healing modalities, specialties and orthopedic procedures typically prescribed for common injuries such as shoulders and extremities. Common diseases are included as well as more innovative diagnostic tools for physical therapists such as radiology. Each chapter features concise information that includes the author's tips, memory aids and "secrets." Bulleted lists, algorithms and illustrations provide a quick review of the specific topic discussed. The information is entirely evidence-based, outcome based and up-to-date.All chapters provide an emphasis on outcome studies and evidence-based practice and include the latest research for the concepts...

Comprehensive Dermatologic Drug Therapy: Expert Consult - Online and Print, 3e (Wolverton, Comprehensive Dermatologic Drug Therapy)

Comprehensive Dermatologic Drug Therapy: Expert Consult - Online and Print, 3e (Wolverton, Comprehensive Dermatologic Drug Therapy)
by Stephen E Wolverton (Author), Stephen E. Wolverton MD (Author)


Safely and effectively treat a full range of skin disorders with Comprehensive Dermatologic Drug Therapy, 3rd Edition! This trusted dermatology reference provides concise, complete, up-to-date guidance on today's full spectrum of topical, intralesional, and systemic drugs. Dr. Steven E. Wolverton and a team of leading international experts clearly explain what drugs to use, when to use them, and what to watch out for.Prescribe with confidence thanks to quick-access summaries of indications/contraindications, dosage guidelines, drug interactions, drug monitoring guidelines, adverse effects, and treatment protocols.Assess your knowledge and prepare for certification or recertification with more than 800 review questions and answers throughout the book.Contain costs and meet patient...

Cognitive Therapy of Depression (Guilford Clinical Psychology and Psychopathology)

Cognitive Therapy of Depression (Guilford Clinical Psychology and Psychopathology)
by Aaron T. Beck (Author), A. John Rush (Author), Brian F. Shaw (Author), Gary Emery (Author)


This bestselling, classic work offers a definitive presentation of the theory and practice of cognitive therapy for depression. Aaron T. Beck and his associates set forth their seminal argument that depression arises from a "cognitive triad" of errors and from the idiosyncratic way that one infers, recollects, and generalizes. From the initial interview to termination, many helpful case examples demonstrate how cognitive-behavioral interventions can loosen the grip of "depressogenic" thoughts and assumptions. Guidance is provided for working with individuals and groups to address the full range of problems that patients face, including suicidal ideation and possible relapse.

 

© 2015 BrightSurf.com